[go: up one dir, main page]

AU2015242879A8 - Melatonin secretion regulator, and method for regulating melatonin secretion - Google Patents

Melatonin secretion regulator, and method for regulating melatonin secretion

Info

Publication number
AU2015242879A8
AU2015242879A8 AU2015242879A AU2015242879A AU2015242879A8 AU 2015242879 A8 AU2015242879 A8 AU 2015242879A8 AU 2015242879 A AU2015242879 A AU 2015242879A AU 2015242879 A AU2015242879 A AU 2015242879A AU 2015242879 A8 AU2015242879 A8 AU 2015242879A8
Authority
AU
Australia
Prior art keywords
melatonin secretion
regulating
regulator
melatonin
secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015242879A
Other versions
AU2015242879A1 (en
Inventor
Saori AKIZUKI
Yukihiro HISHIDA
Ayako Kamimura
Mami Nebashi
Shinobu Yasuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyushu University NUC
Kyowa Hakko Bio Co Ltd
Original Assignee
Kyushu University NUC
Kyowa Hakko Bio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyushu University NUC, Kyowa Hakko Bio Co Ltd filed Critical Kyushu University NUC
Publication of AU2015242879A1 publication Critical patent/AU2015242879A1/en
Publication of AU2015242879A8 publication Critical patent/AU2015242879A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)

Abstract

　The problem of the present invention is to provide a melatonin secretion regulator capable of regulating melatonin secretion in vivo; this problem is solved by providing a melatonin secretion regulator containing ornithine or a salt thereof as an active ingredient.
AU2015242879A 2014-03-31 2015-03-31 Melatonin secretion regulator, and method for regulating melatonin secretion Abandoned AU2015242879A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014072675 2014-03-31
JP2014-072675 2014-03-31
PCT/JP2015/060283 WO2015152311A1 (en) 2014-03-31 2015-03-31 Melatonin secretion regulator, and method for regulating melatonin secretion

Publications (2)

Publication Number Publication Date
AU2015242879A1 AU2015242879A1 (en) 2016-10-20
AU2015242879A8 true AU2015242879A8 (en) 2016-11-10

Family

ID=54240629

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015242879A Abandoned AU2015242879A1 (en) 2014-03-31 2015-03-31 Melatonin secretion regulator, and method for regulating melatonin secretion

Country Status (5)

Country Link
JP (1) JP6594858B2 (en)
CN (1) CN106163510A (en)
AU (1) AU2015242879A1 (en)
SG (1) SG11201608082XA (en)
WO (1) WO2015152311A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019182775A (en) * 2018-04-09 2019-10-24 キリンホールディングス株式会社 Compositions for promoting delayed melatonin secretion onset time, compositions for improving early wakening and compositions for improving advanced circadian rhythm phase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5053535B2 (en) * 2005-05-13 2012-10-17 協和発酵バイオ株式会社 Oral for improving sleep or waking up
JP5649265B2 (en) * 2006-07-27 2015-01-07 江崎グリコ株式会社 Sleep improver

Also Published As

Publication number Publication date
AU2015242879A1 (en) 2016-10-20
WO2015152311A1 (en) 2015-10-08
JPWO2015152311A1 (en) 2017-04-13
SG11201608082XA (en) 2016-11-29
JP6594858B2 (en) 2019-10-23
CN106163510A (en) 2016-11-23

Similar Documents

Publication Publication Date Title
EP4403138A3 (en) Device and method with reduced pacemaker rate in heart valve replacement
MX2017013562A (en) Microbiome regulators and related uses thereof.
MX2017003516A (en) Pyrazole derivatives as sgc stimulators.
CA2900779C (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
SG10201809427SA (en) Insulin receptor partial agonists
EP4351045A3 (en) Methods and apparatus for setting subband csi-related parameters
SG10201810879VA (en) Pharmaceutical compounds
EP3604535A3 (en) Methods and compositions for weed control
MX2021015102A (en) Colony stimulating factor-1 receptor (csf-1r) inhibitors.
JO3466B1 (en) Tetrahydropyridopyrazines modulators of gpr6
EP4268860A3 (en) Compositions, devices, kits and methods for attaching stent-containing medical devices to tissue
TW201612319A (en) Microorganism producing O-phosphoserine and a method for producing O-phosphoserine or L-cysteine using the same
PH12017500533A1 (en) 1-alkyl-6-oxo-1, 6-dihydropyridin-3-yl compounds and use as sgrm modulators
EP3263119A4 (en) Composition including extracellular vesicles derived from bacteria of bacillus sp. for treating pregnancy-associated diseases
SA517390475B1 (en) System of Multiple Bags and Method for The Preparation of Hemocomponents
WO2014160281A3 (en) Method of enhancing delivery of therapeutic compounds to the eye
WO2014145897A3 (en) Immunotherapy system and method thereof
MX2016004325A (en) Novel derivative of an insulin analogue.
ZA201703467B (en) Methods of treating ocular conditions
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
SG10201908248PA (en) Processes for preparing fluoroketolides
EP3549582A3 (en) Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
MY195763A (en) A Herbicidal Composition and Process Thereof
MY183051A (en) Composition containing material for regulating expression of abh antigens
AU2015242879A1 (en) Melatonin secretion regulator, and method for regulating melatonin secretion

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 30 , NO 42 , PAGE(S) 6165 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, APPLICATION NO. 2015242879, UNDER INID (71) ADD CO-APPLICANT KYOWA HAKKO BIO CO., LTD.

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted